Discontinuation report LIORESAL D.S. TAB 20MG

Last updated on 2020-02-24 History
Report ID 103075
Drug Identification Number 00636576
Brand name LIORESAL D.S. TAB 20MG
Common or Proper name LIORESAL D.S. 20MG CT 100'S
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) BACLOFEN
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100'S
ATC code M03BX
ATC description MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2020-01-31
Actual discontinuation date 2020-01-31
Remaining supply date 2020-01-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply Lot on remaining supply expires June 30, 2020
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 700 RUE SAINT-HUBERT
MONTREAL, QUEBEC
CANADA H2Y 0C1
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-02-24 French Compare
v3 2020-02-24 English Compare
v2 2020-01-10 French Compare
v1 2020-01-10 English Compare

Showing 1 to 4 of 4